On the public citation graph

Distinct in vivo target occupancy by bivalent‐ and induced‐fit‐like binding drugs

0 signed · 71 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/med.21307openalex-snapshot
Drug‐Target Residence Time—A Case for G Protein‐Coupled Receptors
inferredcites →https://doi.org/10.1007/bf02353538openalex-snapshot
The Bateman function revisited: A critical reevaluation of the quantitative expressions to characterize concentrations in the one compartment body model as a function of time with first-order invasion and first-order elimination
inferredcites →https://doi.org/10.1007/s00210-013-0881-0openalex-snapshot
Simplified models for heterobivalent ligand binding: when are they applicable and which are the factors that affect their target residence time
inferredcites →https://doi.org/10.1016/0006-8993(80)90229-2openalex-snapshot
Opiate antagonist receptor binding in vivo: evidence for a new receptor binding model
inferredcites →https://doi.org/10.1016/0024-3205(93)90729-mopenalex-snapshot
Formoterol: Pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective β2-adrenoceptor agonist bronchodilator
inferredcites →https://doi.org/10.1016/j.bmcl.2015.02.027openalex-snapshot
Design strategies to address kinetics of drug binding and residence time
inferredcites →https://doi.org/10.1016/j.bpj.2011.11.2241openalex-snapshot
Pathway and Mechanism of Drug Binding to G-Protein-Coupled Receptors
inferredcites →https://doi.org/10.1016/j.cbpa.2010.06.176openalex-snapshot
Drug–target residence time: critical information for lead optimization
inferredcites →https://doi.org/10.1016/j.ddtec.2015.08.003openalex-snapshot
On-rate based optimization of structure–kinetic relationship – surfing the kinetic map
inferredcites →https://doi.org/10.1016/j.ddtec.2015.08.004openalex-snapshot
Kinetic binding assays for the analysis of protein–ligand interactions
inferredcites →https://doi.org/10.1016/j.drudis.2008.12.011openalex-snapshot
Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations
inferredcites →https://doi.org/10.1016/j.drudis.2011.06.013openalex-snapshot
Target–drug interactions: first principles and their application to drug discovery
inferredcites →https://doi.org/10.1016/j.drudis.2013.02.010openalex-snapshot
Pharmacokinetics and the drug–target residence time concept
inferredcites →https://doi.org/10.1016/j.drudis.2015.07.015openalex-snapshot
Can residence time offer a useful strategy to target agonist drugs for sustained GPCR responses?
inferredcites →https://doi.org/10.1016/j.tips.2006.05.001openalex-snapshot
Slow antagonist dissociation and long-lasting in vivo receptor protection
inferredcites →https://doi.org/10.1016/j.tips.2016.06.008openalex-snapshot
In vivo Target Residence Time and Kinetic Selectivity: The Association Rate Constant as Determinant
inferredcites →https://doi.org/10.1016/s0006-2952(00)00546-3openalex-snapshot
A two-state receptor model for the interaction between angiotensin II type 1 receptors and non-peptide antagonists
inferredcites →https://doi.org/10.1016/s0006-3495(95)80298-5openalex-snapshot
Approximating the effects of diffusion on reversible reactions at the cell surface: ligand-receptor kinetics
inferredcites →https://doi.org/10.1016/s0014-2999(98)00965-0openalex-snapshot
Binding of the antagonist []candesartan to angiotensin II AT1 receptor-tranfected Chinese hamster ovary cells
inferredcites →https://doi.org/10.1016/s0021-9258(19)41384-7openalex-snapshot
Determination of dissociation constants and specific rate constants of enzyme-substrate (or protein-ligand) interactions from rapid reaction kinetic data
inferredcites →https://doi.org/10.1016/s1380-2933(97)00067-5openalex-snapshot
New protein engineering approaches to multivalent and bispecific antibody fragments
inferredcites →https://doi.org/10.1021/bi8002023openalex-snapshot
Residence Time of Receptor−Ligand Complexes and Its Effect on Biological Function
inferredcites →https://doi.org/10.1021/ja4087648openalex-snapshot
Hybrid Bombesin Analogues: Combining an Agonist and an Antagonist in Defined Distances for Optimized Tumor Targeting
inferredcites →https://doi.org/10.1038/27227openalex-snapshot
Spanning binding sites on allosteric proteins with polymer-linked ligand dimers
inferredcites →https://doi.org/10.1038/nature12000openalex-snapshot
Conformational biosensors reveal GPCR signalling from endosomes
inferredcites →https://doi.org/10.1038/nbt1142openalex-snapshot
Engineered antibody fragments and the rise of single domains
inferredcites →https://doi.org/10.1038/nchembio.1795openalex-snapshot
Which trails are your drugs taking?
inferredcites →https://doi.org/10.1038/nchembio.1796openalex-snapshot
Translating slow-binding inhibition kinetics into cellular and in vivo effects
inferredcites →https://doi.org/10.1038/nchembio.2210openalex-snapshot
Potent and selective bivalent inhibitors of BET bromodomains
inferredcites →https://doi.org/10.1038/nchembio0108-16openalex-snapshot
IP7 guards the CDK gate
inferredcites →https://doi.org/10.1038/nrd.2015.18openalex-snapshot
The drug–target residence time model: a 10-year retrospective
inferredcites →https://doi.org/10.1038/nrd1500openalex-snapshot
Biochemical mechanisms of drug action: what does it take for success?
inferredcites →https://doi.org/10.1038/nrd2082openalex-snapshot
Drug–target residence time and its implications for lead optimization
inferredcites →https://doi.org/10.1038/nrd3480openalex-snapshot
How were new medicines discovered?
inferredcites →https://doi.org/10.1039/c2md20015eopenalex-snapshot
Determination of drug–receptor residence times by radioligand binding and functional assays: experimental strategies and physiological relevance
inferredcites →https://doi.org/10.1039/c3mb25471bopenalex-snapshot
A comprehensive analysis of the influence of drug binding kinetics on drug action at molecular and systems levels
inferredcites →https://doi.org/10.1053/prrv.2000.0102openalex-snapshot
Beta2-adrenoceptors: mechanisms of action of beta2-agonists
inferredcites →https://doi.org/10.1073/pnas.1104614108openalex-snapshot
Pathway and mechanism of drug binding to G-protein-coupled receptors
inferredcites →https://doi.org/10.1089/cbr.2009.0627openalex-snapshot
Affinity and Avidity in Antibody-Based Tumor Targeting
inferredcites →https://doi.org/10.1093/nar/gkv1037openalex-snapshot
The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
inferredcites →https://doi.org/10.1111/bcp.12996openalex-snapshot
Cell membranes… and how long drugs may exert beneficial pharmacological activityin vivo
inferredcites →https://doi.org/10.1111/bph.12106openalex-snapshot
Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands
inferredcites →https://doi.org/10.1111/bph.13053openalex-snapshot
‘Partial’ competition of heterobivalent ligand binding may be mistaken for allosteric interactions: a comparison of different target interaction models
inferredcites →https://doi.org/10.1111/bph.13347openalex-snapshot
The Concise Guide to PHARMACOLOGY 2015/16: Overview
inferredcites →https://doi.org/10.1111/bph.13445openalex-snapshot
On the different experimental manifestations of two‐state ‘induced‐fit’ binding of drugs to their cellular targets
inferredcites →https://doi.org/10.1111/bph.13504openalex-snapshot
Effects of target binding kinetics onin vivodrug efficacy: koff, konand rebinding
inferredcites →https://doi.org/10.1111/bph.13989openalex-snapshot
Distinct in vivo target occupancy by bivalent‐ and induced‐fit‐like binding drugs
inferredcites →https://doi.org/10.1111/j.1476-5381.2010.00936.xopenalex-snapshot
Long‐lasting target binding and rebinding as mechanisms to prolongin vivodrug action
inferredcites →https://doi.org/10.1124/mol.113.090209openalex-snapshot
Observed Drug-Receptor Association Rates Are Governed by Membrane Affinity: The Importance of Establishing “Micro-Pharmacokinetic/Pharmacodynamic Relationships” at the β2-Adrenoceptor
inferredcites →https://doi.org/10.1124/pr.55.4.4openalex-snapshot
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology
inferredcites →https://doi.org/10.1517/17460441.2010.512037openalex-snapshot
Rebinding: or why drugs may act longerin vivothan expected from theirin vitrotarget residence time
inferredcites →https://doi.org/10.1517/17460441.2015.1067196openalex-snapshot
On the ‘micro’-pharmacodynamic and pharmacokinetic mechanisms that contribute to long-lasting drug action
inferredcites →https://doi.org/10.1517/17460441.2016.1100163openalex-snapshot
Mechanistic models enable the rational use ofin vitrodrug-target binding kinetics for better drug effects in patients
inferredcites →https://doi.org/10.1517/17460441003677725openalex-snapshot
The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety
inferredcites →https://doi.org/10.1529/biophysj.104.045674openalex-snapshot
Effects of the Geometry of the Immunological Synapse on the Delivery of Effector Molecules
inferredcites →https://doi.org/10.2174/1568026615666150701113054openalex-snapshot
The Role of Binding Kinetics in GPCR Drug Discovery
inferredcites →https://doi.org/10.2174/187231310790226215openalex-snapshot
Structural Mechanisms of Slow-Onset, Two-Step Enzyme Inhibition
inferredcites →https://doi.org/10.4155/fmc.11.112openalex-snapshot
Conformational Adaptation in Drug–Target Interactions and Residence Time

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/prp2.847openalex-snapshot
Induced fit versus conformational selection: From rate constants to fluxes… and back to rate constants
inferred← citeshttps://doi.org/10.1016/b978-0-12-820472-6.00011-6openalex-snapshot
Kinetics of Drug-Target Binding: A Guide for Drug Discovery
inferred← citeshttps://doi.org/10.1016/j.phrs.2024.107211openalex-snapshot
A Pharmacological perspective on the temporal properties of sweeteners
inferred← citeshttps://doi.org/10.1016/j.tips.2020.10.003openalex-snapshot
Fluxes for Unraveling Complex Binding Mechanisms
inferred← citeshttps://doi.org/10.1039/c8md00296gopenalex-snapshot
Link between a high k on for drug binding and a fast clinical action: to be or not to be?
inferred← citeshttps://doi.org/10.1056/nejmoa2204041openalex-snapshot
Rare Antagonistic Leptin Variants and Severe, Early-Onset Obesity
inferred← citeshttps://doi.org/10.1101/2023.06.29.547035openalex-snapshot
Competition between induced fit- and conformational selection binding: how different flux-based approaches help clarifying their interplay
inferred← citeshttps://doi.org/10.1111/bph.13445openalex-snapshot
On the different experimental manifestations of two‐state ‘induced‐fit’ binding of drugs to their cellular targets
inferred← citeshttps://doi.org/10.1111/bph.70622openalex-snapshot
Receptor kinetics: Binding flux‐based approaches offer complementary insight into how ligand binding evolves with time
inferred← citeshttps://doi.org/10.1124/jpet.120.265868openalex-snapshot
Slow-, Tight-Binding Inhibition of CYP17A1 by Abiraterone Redefines Its Kinetic Selectivity and Dosing Regimen
inferred← citeshttps://doi.org/10.3390/biom9090493openalex-snapshot
Utilizing the Combination of Binding Kinetics and Micro-Pharmacokinetics Link in Vitro α-Glucosidase Inhibition to in Vivo Target Occupancy
inferred← citeshttps://doi.org/10.3390/biomedicines10010022openalex-snapshot
Evidence for Two Modes of Binding of the Negative Allosteric Modulator SB269,652 to the Dopamine D2 Receptor
showing the first 12 of 13 · page through all 13
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.